Hospital-at-Home Care Depends on the Handoff
Hospital-at-home services become credible when the clinical boundary, escalation route, workforce, equipment, and information handoff are designed together.
By Arman K
Read brief
Latest briefings
All recent healthcare signals in one place
Scan the active archive by date, topic, and story context across healthcare markets, policy, technology, and care delivery.
Medical Device Recalls Need a Post-Market Surveillance Lens
Medical device recalls are easier to assess when a report is tied to the specific failure mode, the affected population, and the corrective action rather than the recall class alone.
By Arman K
Read brief
Medical Device Usability Engineering: Market Signals
Usability engineering claims for medical devices are easier to assess when a validation study is tied to the actual intended user population and use environment rather than a general design-review checklist.
By Arman K
Read brief
Medical Device Cybersecurity Disclosure: Market Signals
A device that cannot describe its own software cannot be patched on a schedule anyone can trust.
By Arman K
Read brief
Single-Use Device Reprocessing: Market Signals
Reprocessing single-use devices can cut supply costs and waste, but only when validation, labeling, and liability are treated as the product, not the paperwork around it.
By Arman K
Read brief
Medical Device Interoperability Standards: Market Signals
Medical device interoperability is less a single technology purchase than an ongoing governance discipline, and the standards a hospital chooses today determine how much integration work it repeats tomorrow.
By Arman K
Read brief
Combination Products Regulatory Pathway: Market Signals
A drug-device combination product's regulatory fate is decided less by its clinical promise than by which FDA center gets named lead reviewer, and that determination deserves the same scrutiny a buyer gives any other structural risk factor.
By Arman K
Read brief
Medical Device Labeling and IFU Clarity: Market Signals
Clear instructions for use are a design problem before they are a compliance problem, and manufacturers who treat IFU comprehension as an afterthought inherit avoidable field risk.
By Arman K
Read brief
Medical Device Supply Chain Resilience: Market Signals
Medical device supply chains fail quietly at the single-source component, not at the finished-product line, and resilience planning has to start where the risk actually sits.
By Arman K
Read brief
Medical Device Real-World Performance Monitoring: Market Signals
A device's pre-market trial answers whether it can work; post-market real-world evidence answers whether it does work, in the patients and settings the trial never enrolled.
By Arman K
Read brief
Medical Device End-of-Life and Decommissioning: Market Signals
Retiring a medical device is a data security and compliance event, not a facilities task, and treating it as the latter is where most exposure starts.
By Arman K
Read brief
Clinical Data Exchange Governance Needs an Accountability Map
Data exchange is not only a technical connection. The operational test is whether the next action, owner, and evidence are visible.
By Arman K
Read brief